Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage

[1]  Jian-Zhi Wang,et al.  Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration , 2022, EBioMedicine.

[2]  R. Vemuganti,et al.  MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery , 2022, Translational Stroke Research.

[3]  R. Vemuganti,et al.  Tenascin-C induction exacerbates post-stroke brain damage , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  C. Jara,et al.  Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice , 2021, Scientific Reports.

[5]  R. Vemuganti,et al.  Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Esther J Pearl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research , 2020, PLoS biology.

[7]  M. Alonso-Vanegas,et al.  GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy , 2020, Frontiers in Cellular Neuroscience.

[8]  P. Fraser,et al.  Behavioral Abnormalities in Knockout and Humanized Tau Mice , 2020, Frontiers in Endocrinology.

[9]  Hua Jiang,et al.  Tau as a potential therapeutic target for ischemic stroke , 2019, Aging.

[10]  R. Vemuganti,et al.  Transient Focal Ischemia Significantly Alters the m6A Epitranscriptomic Tagging of RNAs in the Brain. , 2019, Stroke.

[11]  Mary S. Lopez,et al.  The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein , 2018, Science Signaling.

[12]  R. Pluta,et al.  Tau Protein Dysfunction after Brain Ischemia , 2018, Journal of Alzheimer's disease : JAD.

[13]  Emily C Turner,et al.  Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits , 2018, Aging Cell.

[14]  T. Fath,et al.  Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.

[15]  R. Vemuganti,et al.  Circular RNA Expression Profiles Alter Significantly in Mouse Brain After Transient Focal Ischemia , 2017, Stroke.

[16]  Wendy Noble,et al.  Roles of tau protein in health and disease , 2017, Acta Neuropathologica.

[17]  F. Guan,et al.  GSK-3β as a target for protection against transient cerebral ischemia , 2017, International journal of medical sciences.

[18]  R. Dempsey,et al.  Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage , 2016, The Journal of Neuroscience.

[19]  Qingwu Yang,et al.  GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats , 2016, Molecular Neurobiology.

[20]  R. Vemuganti,et al.  Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins , 2015, The Journal of Neuroscience.

[21]  Wei Wang,et al.  GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats , 2015, Molecular Neurobiology.

[22]  L. McCullough,et al.  Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1 , 2015, Learning & memory.

[23]  J. Goudreau,et al.  GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein , 2014, Cell Death and Differentiation.

[24]  Elisabeth L. Moussaud-Lamodière,et al.  Alpha-synuclein and tau: teammates in neurodegeneration? , 2014, Molecular Neurodegeneration.

[25]  Elisabeth L. Moussaud-Lamodière,et al.  Alpha-synuclein and tau: teammates in neurodegeneration? , 2014, Molecular Neurodegeneration.

[26]  G. Perry,et al.  Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.

[27]  D. Butterfield,et al.  Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. , 2014, Free radical biology & medicine.

[28]  W. Rocca,et al.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. , 2013, JAMA neurology.

[29]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[30]  A. Bush,et al.  GSK-3 in Neurodegenerative Diseases , 2011, International journal of Alzheimer's disease.

[31]  S. Lule,et al.  Alpha-Synuclein Aggregation Induced by Brief Ischemia Negatively Impacts Neuronal Survival in vivo: A Study in [A30P]alpha-Synuclein Transgenic Mouse , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  J. Trojanowski,et al.  Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline , 2010, The Journal of Neuroscience.

[33]  T. Duka,et al.  α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  R. Postina.  A closer look at alpha-secretase. , 2008, Current Alzheimer research.

[35]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[36]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[37]  J. Simpkins,et al.  Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. , 2007, Biochimica et biophysica acta.

[38]  W. Gordon-Krajcer,et al.  Differential Changes in Phosphorylation of Tau at PHF-1 and 12E8 Epitopes During Brain Ischemia and Reperfusion in Gerbils , 2007, Neurochemical Research.

[39]  J. Goudreau,et al.  Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  K. Fukunaga,et al.  Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. , 2006, Biochemical and biophysical research communications.

[41]  A. Lang,et al.  Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.

[42]  J. Trojanowski,et al.  Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam , 2002 .

[43]  Nancy Ratner,et al.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.

[44]  J. Trojanowski,et al.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. , 2002, The American journal of pathology.